Vitamin C.
The vitamin that prevented scurvy, launched the first clinical trial, and became the megadose myth — all in one molecule?
Vitamin C (ascorbic acid) is the vitamin that prevented scurvy — the deficiency disease that killed more sailors than shipwrecks and storms combined, and whose cure-by-citrus gave the vitamin its place in medical history. It is a required cofactor for collagen synthesis (every wound healed, every blood vessel maintained, every bone frame built), carnitine production (the fat-to-energy transport), and neurotransmitter synthesis — plus the body's major water-soluble antioxidant network. The honest calibration for the most-famous vitamin on earth: the RDA is 75–90 mg (a fraction of the shelf's grams), the cold evidence shows modest duration reduction (~8% in adults — real, not the megadose cure the Pauling era promised), and the high-dose ceiling is real: doses above ~1,000 mg/day raise urinary oxalate and stone risk for the susceptible.
Ascorbic Acid (C₆H₈O₆)
A simple sugar-acid molecule the human body cannot synthesize (we lost the L-gulonolactone oxidase gene — the enzyme most mammals use to make their own vitamin C from glucose). The consequence: humans, guinea pigs, some bats, and certain birds must obtain the vitamin entirely from diet. The body pool is ~1,500 mg at saturation, turned over in weeks — no long-term storage organ.
The headline role: vitamin C is a required cofactor for the enzymes that cross-link collagen — without it, the framework fails (scurvy's bleeding gums, wound breakdown, and blood-vessel fragility are the deficiency's architecture).
The body's primary water-soluble antioxidant: vitamin C neutralizes free radicals in blood and cellular fluid, and regenerates vitamin E (the fat-soluble antioxidant) after it's spent — the antioxidant recycling system.
Converts plant (non-heme) iron into its absorbable form — the reason our anemia page teaches vitamin C as the pairing partner with plant iron.
Vitamin C is required for carnitine production — the molecule that transports fat into mitochondria for energy. The connection between deficiency and fatigue.
The immune cells concentrate vitamin C; the deficiency impairs neutrophil and T-cell function. The cold-duration evidence (modest, real) runs through this biology.
Vitamin C is a cofactor for dopamine→norepinephrine conversion — the brain chemistry link that makes the deficiency a cognitive and mood event.
The mechanism has two faces. As a cofactor: vitamin C keeps iron and copper atoms in the enzyme active sites in their reduced states — the collagen hydroxylases cannot function without it, which is why scurvy is the failure of every collagen-dependent structure simultaneously. As an antioxidant: the molecule donates electrons to neutralize free radicals, becoming oxidized itself (dehydroascorbic acid) — then is recycled back to active form by glutathione, the cellular antioxidant system. The absorption has a ceiling: the active transporters saturate around 200 mg per sitting, meaning that the megadose tablet's excess simply remains unabsorbed (the reason megadose pharmacology pivoted to liposomal and IV delivery).
Plain Ascorbic Acid
The standard, cheapest form
Liposomal
Higher plasma levels per gram
Buffered (Calcium Ascorbate)
Gentle on the stomach
Megadose IV Protocols
Medical procedure, not wellness
Plain Ascorbic Acid ✅ (The Standard)
The studied, cheapest, most-stable form — every trial material. The absorption ceiling (~200 mg per sitting via active transport) is the limitation, managed by splitting doses. The GI upset at higher doses is the form's known trade-off, addressed by the buffered alternative.
Buffered (Calcium Ascorbate)
The non-acidic salt: pH-neutral, gentle on the stomach — the practical form for the acid-sensitive. The 'Ester-C' metabolite-complex claims of superior retention are modestly supported, modestly meaningful. The calcium content counts toward your total (our osteoporosis page's arithmetic).
Liposomal — The Delivery Premium
Phospholipid-encapsulated vitamin C: the liposomes bypass the active-transport saturation (higher plasma levels per gram — the pharmacokinetic advantage is real). The honest boundary: the clinical superiority (better cold outcome, better urate effect) over plain ascorbic acid is NOT established — the premium buys the absorption, not the proven benefit. Reasonable for those who want the pharmacokinetic edge; not a clinical upgrade.
The Goat Arithmetic — The Lost Gene
The most thought-provoking fact in vitamin C biology: most mammals synthesize their own vitamin C from glucose in the liver — a goat produces roughly 13,000 mg daily, more under stress (the synthesis rises with the oxidative demand). Humans cannot: the gene for L-gulonolactone oxidase (the final enzyme in the pathway) is a pseudogene in humans, guinea pigs, some bats, and certain birds — a shared mutation, inherited from a primate ancestor whose fruit-rich diet presumably made the enzyme unnecessary.
The Linus Pauling megadose argument leaned on this fact: if the goat makes 13,000 mg, shouldn't we take grams? The counter-reading: the goat's production is internal, regulated, and titrated to demand — the megadose tablet's absorption ceiling (~200 mg per sitting) and the kidney's rapid clearance of the excess make the oral comparison misleading. The body that lost the enzyme also evolved efficient recycling (the dehydroascorbate system reclaims spent vitamin C), suggesting the dietary 75–90 mg RDA is the adaptation, not the deficiency. The goat is an interesting fact, not a dosing instruction.
The scurvy threshold makes the same point in deficiency form: 10 mg daily prevents scurvy (the disease disappears), the RDA is 75–90 mg (a margin for the pool and the nonsmoker's oxidative load), and smokers need +35 mg (the oxidative burden). The gap between 'prevents the killer disease' and 'the RDA' is one order of magnitude — and the gap between the RDA and the Pauling dose is another, bridged by marketing rather than trials.
- RDA: 75 mg (women) / 90 mg (men); smokers +35 mg; the scurvy floor is ~10 mg.
- The absorption ceiling: ~200 mg per sitting via active transport — megadose tablets deliver a fraction of their label.
- The saturation pool: ~1,500 mg body pool at saturation, turned over in weeks — no long-term storage.
- The lost gene: humans, guinea pigs, some bats — the animals that must eat their vitamin C.
- The kidney role: the kidneys filter and reabsorb vitamin C below the pool's saturation; the excess appears in urine within hours (the reason megadoses are expensive urine).
What It Does NOT Do
The honest negative space — the megadose myth's persistent afterlife:
- It does not prevent colds in the general population. The Cochrane verdict, one of the field's cleanest: regular supplementation does NOT reduce cold incidence in the general population. It reduces duration (~8% in adults, ~14% in children) — modest, real, and consistently oversold.
- It does not cure cancer. The IV-megadose oncology trials have been consistently disappointing — the Pauling-era claims and the subsequent decades of high-dose research produced nulls, not cures. The pharmacologic IV route remains an experimental (not standard) therapy.
- It does not need to be taken at 1,000 mg+ daily. The RDA is 75–90 mg; the trials showing benefits used 500–1,000 mg; the megadose habit is a marketing artifact with real oxalate cost.
- It does not acidify urine usefully (the UTI myth). The old idea that vitamin C acidifies urine to kill bacteria — our UTI page's teardown — is retired: the evidence doesn't support it, and the megadoses required are the stone-risk territory.
- It does not 'boost' immunity on demand. The immune cells concentrate the vitamin and deficiency impairs their function — but the replete majority's additional vitamin C doesn't supercharge anything. The correction-not-optimization principle, the estate's recurring lesson.